From: A high performance profile-biomarker diagnosis for mass spectral profiles
Algorithms | MICA-SVM | PLS-REG | NR-LLD | RPLS-LLD |
---|---|---|---|---|
Data | Average classification rates under the 100 trials of 50% HOCV (%) | |||
Colorectal | 99.05±01.82 | 96.64±02.19 | 97.02±01.78 | 96.23±02.32 |
HCC | 99.07±01.03 | 94.60±02.12 | 91.09±02.65 | 94.40±02.19 |
Ovarian-qaqc | 99.09±01.09 | 95.44±02.00 | 98.18±01.52 | 96.68±02.00 |
Prostate | 99.36±00.99 | 98.32±01.43 | 96.74±01.97 | 98.32±01.47 |
Cirrhotic | 99.52±00.85 | 91.36±03.44 | 89.82±03.50 | 92.84±02.36 |
Three-class | 97.37±01.20 | 68.51±04.82 | 84.04±03.66 | 85.23±03.31 |
Data | Average classification rates under10-fold CV (%) | |||
Colorectal | 100.0±00.00 | 94.53±08.80 | 98.09±04.03 | 97.18±06.25 |
HCC | 99.33±02.11 | 92.70±07.26 | 93.32±07.26 | 93.37±06.29 |
Ovarian-qaqc | 99.52±01.51 | 98.64±04.31 | 98.18±03.18 | 98.16±02.38 |
Prostate | 100.0±00.00 | 99.32±02.43 | 96.26±05.19 | 99.29±02.26 |
Cirrhotic | 100.0±00.00 | 95.06±07.00 | 89.36±09.60 | 94.36±06.62 |
Three-class | 98.52±03.35 | 77.11±08.23 | 85.99±08.17 | 88.64±06.83 |